MCI Onehealth to Present at Desjardins Digital Healthcare
TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- MCI Onehealth Technologies Inc. (“MCI or “the Company”) (TSX: DRDR), a clinician-led healthcare technology...
Stay updated with breaking news from Fernando Massalin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- MCI Onehealth Technologies Inc. (“MCI or “the Company”) (TSX: DRDR), a clinician-led healthcare technology...
TORONTO, June 24, 2021 (GLOBE NEWSWIRE) -- MCI Onehealth Technologies Inc. ("MCI") (TSX:DRDR) is pleased to announce the voting results from its annual ...
Fernando Massalin | For media enquiries please contact: Nolan Reeds | nolan@mcionehealth.com | +1 (416) 440-4040 ext 158 Forward Looking Statements This press release may contain forward‐looking information and forward-looking statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation, which reflect MCI’s current expectations regarding future events. Forward-looking statements in this press release include statements with respect to the timing of the release of MCI’s financial results for the first quarter of 2021 and the timin...
Article content TORONTO, April 29, 2021 (GLOBE NEWSWIRE) — MCI Onehealth Technologies Inc. (“MCI”) (TSX: DRDR), a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, announces an initial investment in Ariel Precision Medicine, Inc. (“Ariel”) in exchange for a convertible promissory note that is convertible into equity securities in Ariel upon certain events. The investment supports the growth of Ariel while establishing a foundation for a collaborative commercial partnership and future entry for MCI into the United States market. Wi...
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 27, 2021 (GLOBE NEWSWIRE) — MCI Onehealth Technologies Inc. (“MCI”) (TSX: DRDR), a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, has completed its previously announced acquisition of all the issued and outstanding shares (the “Transaction”) of Khure Health Inc. (“Khure”) pursuant to a share purchase agreement. Khure’s precision medicine platform harnesses clinical data, enabling physicians to rapidly screen and identify ...